secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-05-12T23:59:59+00:00
Accession:  0000950170-22-009652
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q1 revenue $3.22M (+289% YoY), net loss $4.49M; GoodWheat launch, HB4 milestone
--------------------------------------------------------------------------------

- Q1 revenue $3.22M (+289% YoY); net loss $4.49M (vs. $2.06M income YoY on prior-year Bioceres gain)
- Operating loss improved to $4.62M from $5.33M YoY; sales up 48% sequentially from Q4 2021
- First retail orders of GoodWheat pasta shipped; Amazon e-commerce launch expected June 2022
- HB4 soybeans approved in China; $2M milestone payment triggered and 6% royalties on future Bioceres revenue

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022009652/0000950170-22-009652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022009652/rkda-20220512.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-009652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer